Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Infertility 1Helping Behavior 1

Interventions

Letrozole 5Clomiphene 4follitropin alfa 2Tamoxifen 2Metformin 2Goserelin 2Cyclophosphamide 2follitropin beta 1cetrorelix 1Urofollitropin 1Triptorelin Pamoate 1Thioctic Acid 1Therapeutics 1Surgical Procedures, Operative 1Sperm Injections, Intracytoplasmic 1Neoadjuvant Therapy 1Congresses as Topic 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Infertility × Urofollitropin × Clear all
NCT01185782 2013-12-27

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
300 enrolled 18 charts

Helping Behavior, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡